Archives

by in
Entry Author Date Location
10 Takeaways From New York’s Life Science Disruptors 03/10/14 New York
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Xconomy Boston’s Top 10 Stories of Q4: Editor’s Picks 12/30/13 Boston
Ariad’s Cancer Drug to Return to U.S. in January, Shares Soar 12/20/13 Boston
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup 11/07/13 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues 10/31/13 Boston
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet 10/09/13 Boston
Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches 05/16/13 Texas
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
Boston News Roundup: Amazon, Akamai, Blend, MC10, & More 12/19/12 Boston
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
East Coast Life Sciences Roundup: Pfizer, Rhythm, NPS, More 10/26/12 Boston
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Ariad Loads Up With $200M Stock Deal, After Big Medical Meeting 12/15/11 Boston
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Ariad’s Second Cancer Drug Found Safer Than Expected in Early Review of Key Study 11/07/11 Boston
Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News 09/23/11 Boston
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
Page 1 of 3 next page »